Schedule of Warrants Activity (Details) - Warrant [Member] |
3 Months Ended |
|---|---|
|
Mar. 31, 2023
$ / shares
shares
| |
| Accumulated Other Comprehensive Income (Loss) [Line Items] | |
| Number of Shares of Common Stock Issuable for Warrants, Beginning Balance | shares | 511,333,351,090 |
| Weighted average exercise price, Beginning Balance | $ / shares | $ 0.00009 |
| Number of Shares of Common Stock Issuable for Warrants, issuance of warrants | shares | |
| Weighted average exercise price issuance of warrants | $ / shares | |
| Number of Shares of Common Stock Issuable for Warrants, expiration of warrants | shares | (1) |
| Weighted average exercise price expiration of warrants | $ / shares | $ (794,998.13) |
| Number of Shares of Common Stock Issuable for Warrants, Ending Balance | shares | 511,333,351,089 |
| Weighted average exercise price, Ending Balance | $ / shares | $ 0.00009 |
| X | ||||||||||
- Definition Expiration of warrants. No definition available.
|
| X | ||||||||||
- Definition Issuance of warrants. No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price, warrants outstanding. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Other increase (decrease) in number of shares reserved for issuance under non-option equity instrument agreements that is not separately disclosed. No definition available.
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|